Sky Century Investment, Inc. (SKYI) Aktienanalyse
Nur zu Informationszwecken. Keine Finanzberatung. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
SKYI steht fuer Sky Century Investment, Inc., ein Healthcare-Unternehmen mit einem Kurs von $ (Marktkapitalisierung 0). Die Aktie erzielt 57/100, eine moderate Bewertung basierend auf 9 quantitativen KPIs.
Zuletzt analysiert: 17. März 2026Sky Century Investment, Inc. (SKYI) Gesundheitswesen & Pipeline-Uebersicht
Sky Century Investment, Inc. is a micro-cap company involved in the sale of CBD products and digital marketing services for the CBD industry, operating with a small team and facing significant competition in the specialty and generic drug manufacturing sector, as well as the digital marketing space.
Investmentthese
Sky Century Investment, Inc. presents a high-risk, high-reward investment profile due to its micro-cap status and involvement in the volatile CBD market. With a market capitalization of $0.00B and a negative P/E ratio of -4.52, the company's financial performance raises concerns. A key value driver would be successful expansion of its CBD product line and digital marketing services, potentially increasing revenue and improving profitability. Growth catalysts include capitalizing on the increasing acceptance and legalization of CBD products. However, potential risks include intense competition, regulatory uncertainty surrounding the CBD industry, and the company's limited resources. Investors should carefully consider these factors before investing.
Basierend auf FMP-Finanzdaten und quantitativer Analyse
Wichtige Highlights
- Market Cap of $0.00B indicates the company's micro-cap status, reflecting its small size and limited market presence.
- P/E Ratio of -4.52 suggests the company is currently not profitable, indicating potential challenges in generating earnings.
- Profit Margin of -116.0% highlights significant losses relative to revenue, raising concerns about the company's financial sustainability.
- Gross Margin of 33.5% indicates the profitability of the company's products and services before operating expenses are considered.
- Beta of 0.88 suggests the stock is slightly less volatile than the overall market.
Wettbewerber & Vergleichsunternehmen
Staerken
- Focus on pharmaceutical-grade ingredients.
- Digital marketing services tailored to the CBD industry.
- Established presence in the CBD market since 2012.
Schwaechen
- Small size and limited resources (1 employee).
- Negative profitability and low market capitalization.
- High dependence on the volatile CBD market.
Katalysatoren
- Ongoing: Increasing acceptance and legalization of CBD products could drive demand.
- Upcoming: Potential partnerships with established healthcare companies.
- Upcoming: Expansion into new geographic markets.
Risiken
- Ongoing: Intense competition in the CBD and digital marketing industries.
- Ongoing: Regulatory uncertainty surrounding the CBD market.
- Potential: Fluctuations in consumer demand for CBD products.
- Potential: Limited financial resources and negative profitability.
- Potential: Dependence on a single employee.
Wachstumschancen
- Expansion of CBD Product Line: Sky Century Investment can explore developing new CBD-infused products, such as topicals, edibles, and beverages, to cater to a broader consumer base. The global CBD market is projected to reach billions of dollars in the coming years, offering significant revenue potential. Timeline: Within the next 1-2 years, the company could launch new product lines, pending regulatory approvals and market research.
- Strategic Partnerships: Collaborating with established healthcare or wellness companies could provide Sky Century Investment with access to wider distribution networks and increased brand recognition. Partnerships could also facilitate research and development efforts, leading to innovative CBD products. Timeline: Initiating partnership discussions within the next 6-12 months could lead to mutually beneficial agreements.
- Geographic Expansion: Targeting new geographic markets, both domestically and internationally, can significantly increase Sky Century Investment's customer base. Identifying regions with favorable CBD regulations and high consumer demand is crucial. Timeline: Market research and regulatory analysis within the next year could pave the way for expansion into new territories.
- Digital Marketing Service Enhancement: Sky Century Investment can enhance its digital marketing services by incorporating emerging technologies such as AI-powered marketing automation and personalized advertising. This can attract more clients in the CBD industry and increase revenue from its service offerings. Timeline: Implementing new digital marketing technologies within the next 6-12 months can improve service efficiency and attract new clients.
- Focus on Pharmaceutical-Grade CBD: Emphasizing the use of pharmaceutical-grade ingredients in its CBD products can differentiate Sky Century Investment from competitors and appeal to health-conscious consumers. This can also open doors to potential collaborations with pharmaceutical companies for research and development. Timeline: Strengthening supply chain relationships and obtaining relevant certifications within the next year can enhance product quality and market credibility.
Chancen
- Expansion into new CBD product lines.
- Strategic partnerships with established healthcare companies.
- Geographic expansion into new markets.
Risiken
- Intense competition in the CBD and digital marketing industries.
- Regulatory uncertainty surrounding the CBD market.
- Fluctuations in consumer demand for CBD products.
Wettbewerbsvorteile
- Focus on pharmaceutical-grade ingredients may provide a quality advantage.
- Digital marketing services tailored to the CBD industry offer a niche specialization.
- Early mover advantage in a rapidly growing market (though competition is increasing).
Ueber SKYI
Sky Century Investment, Inc., incorporated in 2012 and based in Las Vegas, Nevada, operates within the healthcare sector, specifically in the specialty and generic drug manufacturing industry, with a focus on cannabidiol (CBD) products. The company's business model encompasses two primary areas: the sale of CBD products formulated with pharmaceutical-grade ingredients, and the provision of digital marketing services. These services include digital marketing strategy and planning, search engine optimization (SEO), analytics, and reporting. Additionally, Sky Century Investment offers content and website development and mail marketing services tailored for companies involved in the production of CBD products. Given its small size, with only one employee, Sky Century Investment's market reach and operational capacity are limited. The company's focus on the CBD market positions it within a rapidly growing but also highly competitive segment of the healthcare industry. Its dual approach of offering both CBD products and marketing services aims to capitalize on the increasing demand for CBD and the need for effective marketing strategies within this sector.
Was das Unternehmen tut
- Sells cannabidiol (CBD) products.
- Uses pharmaceutical-grade ingredients in CBD products.
- Provides digital marketing services.
- Offers strategy and planning services.
- Provides SEO, analytics, and reporting services.
- Offers content and website development services.
- Provides mail marketing services for CBD companies.
Geschaeftsmodell
- Direct sales of CBD products to consumers.
- Providing digital marketing services to companies in the CBD industry.
- Generating revenue through service fees and product sales.
Branchenkontext
Sky Century Investment, Inc. operates in the rapidly evolving CBD market within the broader healthcare sector. The CBD industry is characterized by increasing consumer demand, driven by perceived health benefits and growing acceptance of cannabis-derived products. However, the market is also highly competitive, with numerous companies vying for market share. Regulatory uncertainty at both the state and federal levels adds another layer of complexity. Sky Century Investment's dual focus on CBD products and digital marketing services positions it to capitalize on the growth of the CBD market, but it faces competition from larger, more established players in both the CBD and digital marketing spaces.
Wichtige Kunden
- Individual consumers seeking CBD products.
- Companies in the CBD industry needing digital marketing services.
- Businesses involved in the production of CBD products.
Finanzdaten
Chart & Info
Sky Century Investment, Inc. (SKYI) Aktienkurs: Price data unavailable
Aktuelle Nachrichten
Keine aktuellen Nachrichten fuer SKYI verfuegbar.
Analystenkonsens
Konsens-Bewertung
Aggregierte Kauf-/Halten-/Verkauf-Empfehlungen von Benzinga, Yahoo Finance und Finnhub fuer SKYI.
Kursziele
Wall-Street-Kurszielanalyse fuer SKYI.
MoonshotScore
Was bedeutet diese Bewertung?
Der MoonshotScore bewertet das Wachstumspotenzial von SKYI auf einer Skala von 0-100 ueber mehrere Faktoren wie Innovation, Marktdisruption, finanzielle Gesundheit und Momentum.
Fuehrung: Nataliia Petranetska
Managing Director
Nataliia Petranetska serves as the Managing Director of Sky Century Investment, Inc. Her background includes experience in managing small teams and overseeing the company's operations in the CBD and digital marketing sectors. She is responsible for the strategic direction and day-to-day management of the company.
Erfolgsbilanz: As the Managing Director, Nataliia Petranetska has focused on establishing Sky Century Investment's presence in the CBD market and developing its digital marketing service offerings. Key milestones under her leadership include expanding the company's product line and securing contracts with CBD companies for marketing services.
SKYI OTC-Marktinformationen
The OTC Other tier represents the lowest tier of the OTC market, indicating that Sky Century Investment, Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited or no financial disclosure, making it difficult for investors to assess their financial health and operational performance. Unlike companies listed on major exchanges like NYSE or NASDAQ, OTC Other companies often have less stringent listing requirements and may be subject to less regulatory oversight.
- OTC-Stufe: OTC Other
- Offenlegungsstatus: Unknown
- Limited financial disclosure due to OTC Other status.
- Low liquidity and potential price volatility.
- Higher risk of fraud or manipulation compared to listed exchanges.
- Limited regulatory oversight.
- Dependence on the volatile CBD market.
- Verify the company's financial statements and SEC filings (if any).
- Research the background and experience of the company's management team.
- Assess the company's competitive position in the CBD market.
- Evaluate the company's compliance with relevant regulations.
- Understand the company's business model and revenue streams.
- Check for any legal or regulatory issues.
- Monitor trading volume and price volatility.
- Company has been in operation since 2012.
- Focus on pharmaceutical-grade ingredients.
- Provides digital marketing services to other CBD companies.
Haeufige Fragen zu SKYI
What are the key factors to evaluate for SKYI?
Sky Century Investment, Inc. (SKYI) currently holds an AI score of 57/100, indicating moderate score. Key strength: Focus on pharmaceutical-grade ingredients.. Primary risk to monitor: Ongoing: Intense competition in the CBD and digital marketing industries.. This is not financial advice.
How frequently does SKYI data refresh on this page?
SKYI prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven SKYI's recent stock price performance?
Recent price movement in Sky Century Investment, Inc. (SKYI) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Focus on pharmaceutical-grade ingredients.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider SKYI overvalued or undervalued right now?
Determining whether Sky Century Investment, Inc. (SKYI) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying SKYI?
Before investing in Sky Century Investment, Inc. (SKYI), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding SKYI to a portfolio?
Potential reasons to consider Sky Century Investment, Inc. (SKYI) depend on individual investment goals and risk tolerance. A key strength identified by analysis: Focus on pharmaceutical-grade ingredients.. Additionally: Digital marketing services tailored to the CBD industry.. Always weigh potential rewards against risks and diversify across holdings. This is not financial advice.
Can I buy fractional shares of SKYI?
Yes, most major brokerages offer fractional shares of Sky Century Investment, Inc. (SKYI) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track SKYI's earnings and financial reports?
Sky Century Investment, Inc. (SKYI) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Setting up alerts through your brokerage for SKYI earnings announcements is recommended.
Haftungsausschluss: Dieser Inhalt dient ausschliesslich zu Informationszwecken und stellt keine Anlageberatung dar. Fuehren Sie immer Ihre eigene Recherche durch und konsultieren Sie einen Finanzberater.
Offizielle Ressourcen
Daten dienen ausschliesslich zu Informationszwecken.
- Limited information available for this company.
- OTC stocks are inherently riskier than exchange-listed stocks.
- AI analysis pending.